RxDoctor Payments DataLook up a doctor →

Winthrop Risk, MD

Neurology · Cedar Rapids, IANPI 1104804053

Payments from drug & device makers

$135,984in general payments, 2019–2025

Across 2,065 payments — averaging $65.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$82K
  • Biohaven Pharmaceutical Holding Company Ltd.$17K
  • Biohaven Pharmaceuticals, Inc.$13K
  • Teva Pharmaceuticals USA, Inc.$8K
  • Pfizer$2K
  • Novartis$1K
  • plus $13K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)379$82,231
Biohaven Pharmaceutical Holding Company Ltd.85$17,147
Biohaven Pharmaceuticals, Inc.74$12,754
Teva Pharmaceuticals USA, Inc.572$7,560
Pfizer133$1,684
Novartis75$1,379
Lilly USA, LLC75$1,131
Axsome Therapeutics, Inc.50$1,086
SK Life Science, Inc.52$805
Supernus Pharmaceuticals, Inc.53$698
Amgen(2 entities)28$663
Harmony Biosciences LLC64$648
EMD Serono, Inc.31$599
Johnson & Johnson26$545
Bristol Myers Squibb30$503
Avanir Pharmaceuticals, Inc.22$479
Otsuka America Pharmaceutical, Inc.23$454
Biogen22$410
Eisai Inc.24$397
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$390
Lundbeck LLC15$360
Sunovion Pharmaceuticals Inc.24$295
Acadia Pharmaceuticals Inc13$289
Neurocrine Biosciences, Inc.22$255
Tanabe Pharma America, Inc.11$254
Kyowa Kirin, Inc.16$243
MDD US Operations, LLC18$216
Amneal Pharmaceuticals LLC9$203
CSL Behring6$199
Sanofi8$171
Argenx US, Inc.7$170
Vanda Pharmaceuticals Inc.8$159
E.r. Squibb & Sons, L.L.C.4$143
Upsher-smith Laboratories LLC6$124
Idorsia Pharmaceuticals US Inc7$121
Merck5$105
TG Therapeutics, Inc.5$104
Acorda Therapeutics, Inc5$101
UCB, Inc.4$100
Adamas Pharmaceuticals, Inc.5$96
Ipsen Biopharmaceuticals, Inc2$85
Catalyst Pharmaceuticals, Inc.4$82
Impel Pharmaceuticals Inc.4$74
Vertex4$72
Takeda Pharmaceuticals U.S.A., Inc.3$69
Neurelis, Inc.2$62
Octapharma USA, Inc.2$41
AstraZeneca2$34
Avion Pharmaceuticals2$31
Genentech USA, Inc.2$30
Almatica Pharma LLC1$23
Ultragenyx Pharmaceutical Inc.1$22
Promius Pharma LLC1$21
Phathom Pharmaceuticals, Inc.1$21
Mallinckrodt Hospital Products Inc.1$17
Metacel Pharmaceuticals LLC1$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$14

How this compares

$135,984 in reported general payments places this provider in the 95th percentile of 132 neurology providers in Iowa.

See all neurology providers in Iowa →

Medicare billing

Part B allowed, 2024
$59,466
Medicare patients
116
Services billed
4,279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Cedar Rapids

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →